| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $40.9M | +25.7% |
| Cost of Revenue | $14.0M | +49.9% |
| Gross Profit | $26.9M | +16.0% |
| R&D Expense | $6.9M | +45.5% |
| SG&A Expense | $14.0M | +12.7% |
| Operating Income | -$14.4M | -132.0% |
| Pre-tax Income | -$15.1M | -159.0% |
| Income Tax | $505K | +38.0% |
| Net Income | -$15.6M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $14.1M | -42.0% |
| Short-term Investments | $4.3M | +764.5% |
| Accounts Receivable | $4.1M | +7.1% |
| Inventory | $3.1M | -1.4% |
| Current Assets | $27.6M | -16.0% |
| Total Assets | $38.6M | -8.5% |
| Current Liabilities | $8.3M | -18.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$14.5M | -341.1% |
| Capital Expenditures | $1.7M | +28.1% |
| Investing Cash Flow | -$7.1M | -2814.8% |
| Financing Cash Flow | $11.4M | -45.4% |
| Free Cash Flow | -$16.3M | -249.5% |
| -151.9% |
| EPS (Basic) | -$0.37 | -131.3% |
| EPS (Diluted) | -$0.37 | -131.3% |
| Long-term Debt |
| $11.2M |
| — |
| Total Liabilities | $27.2M | +55.4% |
| Stockholders' Equity | $11.4M | -53.9% |